Drug Profile
Research programme: liposomal angiogenesis stimulants - Endovasc
Alternative Names: Liposomal angiogenesis stimulants research programme - EndovascLatest Information Update: 24 Apr 2007
Price :
$50
*
At a glance
- Originator Endovasc
- Class
- Mechanism of Action Angiogenesis inducing agents; Intercellular signalling peptide and protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 24 Apr 2007 Discontinued - Preclinical for Cardiovascular disorders in USA (unspecified route)
- 01 Jun 1999 Preclinical development for Cardiovascular disorders in USA (Unknown route)